Therapy of acute myelogenous leukemia in adults.
Borthakur
Gautam
G
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. gborthak@mdanderson.org
Estey
Elihu E
EE
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002869:Chromosome Aberrations; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D050660:Core Binding Factors / Q000235:genetics / Q000502:physiology; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000145:classification / Q000188:drug therapy* / Q000235:genetics / Q000601:surgery; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000235:genetics / Q000502:physiology; D018365:Neoplasm, Residual; D011379:Prognosis; D012074:Remission Induction; D012306:Risk; D016879:Salvage Therapy; D016896:Treatment Outcome
D050660:Core Binding Factors; D009363:Neoplasm Proteins; D003561:Cytarabine; D003630:Daunorubicin